These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 7385835)

  • 21. A woman with recurrent calcium phosphate kidney stones.
    Goldfarb DS
    Clin J Am Soc Nephrol; 2012 Jul; 7(7):1172-8. PubMed ID: 22595827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of recurrent nephrolithiasis.
    Goldfarb DS; Coe FL
    Am Fam Physician; 1999 Nov; 60(8):2269-76. PubMed ID: 10593318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones.
    Bataille P; Charransol G; Gregoire I; Daigre JL; Coevoet B; Makdassi R; Pruna A; Locquet P; Sueur JP; Fournier A
    J Urol; 1983 Aug; 130(2):218-23. PubMed ID: 6876264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
    Kıraç M; Küpeli B; Irkilata L; Gülbahar O; Aksakal N; Karaoğlan U; Bozkırlı I
    Kaohsiung J Med Sci; 2013 Feb; 29(2):88-92. PubMed ID: 23347810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of renal calculi.
    Coe FL; Favus MJ
    Adv Intern Med; 1980; 26():373-92. PubMed ID: 7013442
    [No Abstract]   [Full Text] [Related]  

  • 26. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi].
    Daudon M; Réveillaud RJ
    Nephrologie; 1984; 5(5):195-201. PubMed ID: 6531056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patients.
    Crassweller PO; Oreopoulos DG; Toguri A; Husdan H; Wilson DR; Rapoport A
    J Urol; 1978 Jul; 120(1):6-10. PubMed ID: 671607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family history of renal stones in recurrent stone patients.
    Ljunghall S; Danielson BG; Fellström B; Holmgren K; Johansson G; Wikström B
    Br J Urol; 1985 Aug; 57(4):370-4. PubMed ID: 4027504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and clinical features of renal tubular acidosis-1 in urolithiasis.
    Ito H; Kotake T; Suzuki F
    Urol Int; 1993; 50(2):82-5. PubMed ID: 8460453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic diagnosis of renal lithiasis].
    dos Santos DR; Pinheiro ME; Schor N
    AMB Rev Assoc Med Bras; 1987; 33(7-8):161-3. PubMed ID: 3502502
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxalate crystallization in the kidney in the presence of hyperuricemia.
    Noda S; Hayashi K; Eto K
    Scanning Microsc; 1989 Sep; 3(3):829-35; discussion 835-6. PubMed ID: 2617264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
    Schwille PO; Manoharan M; Schmiedl A
    Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.